
Naturhouse Health (NTH) | Financial Analysis & Statements
Naturhouse Health S.A.U. | Small-cap | Consumer Defensive
Naturhouse Health S.A.U. | Small-cap | Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2020Income Metrics
Revenue
12.0M
Gross Profit
8.6M
72.07%
Operating Income
4.4M
36.53%
Net Income
1.9M
16.01%
Balance Sheet Metrics
Total Assets
42.6M
Total Liabilities
10.9M
Shareholders Equity
31.7M
Debt to Equity
0.34
Cash Flow Metrics
Revenue & Profitability Trend
Naturhouse Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 49.4M | 50.4M | 52.4M | 57.6M | 55.1M |
Cost of Goods Sold | 14.0M | 13.7M | 14.9M | 16.3M | 15.9M |
Gross Profit | 35.5M | 36.7M | 37.5M | 41.3M | 39.2M |
Gross Margin % | 71.8% | 72.8% | 71.5% | 71.6% | 71.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 3.4M | 2.7M | 3.5M | 3.9M | 2.9M |
Other Operating Expenses | 6.7M | 6.0M | 7.9M | 6.6M | 6.7M |
Total Operating Expenses | 10.1M | 8.7M | 11.4M | 10.6M | 9.6M |
Operating Income | 13.1M | 16.3M | 12.8M | 17.5M | 14.4M |
Operating Margin % | 26.6% | 32.3% | 24.5% | 30.5% | 26.1% |
Non-Operating Items | |||||
Interest Income | 542.0K | 43.0K | 111.0K | 361.0K | 24.0K |
Interest Expense | 139.0K | 107.0K | 206.0K | 100.0K | 185.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 13.5M | 15.4M | 13.1M | 18.2M | 13.5M |
Income Tax | 3.7M | 4.2M | 3.5M | 4.9M | 4.1M |
Effective Tax Rate % | 27.2% | 27.0% | 26.6% | 26.7% | 30.5% |
Net Income | 9.9M | 11.2M | 9.6M | 13.4M | 9.4M |
Net Margin % | 20.0% | 22.3% | 18.4% | 23.2% | 17.0% |
Key Metrics | |||||
EBITDA | 16.1M | 18.3M | 15.6M | 21.0M | 18.1M |
EPS (Basic) | - | €0.19 | €0.16 | €0.22 | €0.16 |
EPS (Diluted) | - | €0.19 | €0.16 | €0.22 | €0.16 |
Basic Shares Outstanding | - | 59949480 | 59949480 | 59949480 | 59967740 |
Diluted Shares Outstanding | - | 59949480 | 59949480 | 59949480 | 59967740 |
Income Statement Trend
Naturhouse Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 20.7M | 24.4M | 12.1M | 27.2M | 21.6M |
Short-term Investments | 991.0K | 2.7M | 2.7M | - | - |
Accounts Receivable | 2.0M | 2.5M | 2.4M | 2.7M | 4.0M |
Inventory | 3.4M | 2.8M | 2.7M | 2.6M | 3.3M |
Other Current Assets | - | - | - | 779.0K | 531.0K |
Total Current Assets | 28.2M | 34.4M | 27.1M | 37.3M | 33.4M |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
Goodwill | 371.0K | 444.0K | 609.0K | 753.0K | 972.0K |
Intangible Assets | 371.0K | 444.0K | 609.0K | 753.0K | 972.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 14.4M | 14.5M | 15.8M | 11.7M | 9.1M |
Total Assets | 42.6M | 48.8M | 42.8M | 49.0M | 42.6M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 3.6M | 4.1M | 3.4M | 3.2M | 5.7M |
Short-term Debt | 880.0K | 1.4M | 1.2M | 894.0K | 1.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 6.5M | 12.8M | 8.4M | 8.1M | 9.7M |
Non-Current Liabilities | |||||
Long-term Debt | 2.2M | 1.8M | 2.1M | 1.3M | 2.5M |
Deferred Tax Liabilities | 244.0K | 275.0K | 306.0K | 294.0K | 154.0K |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 4.4M | 5.5M | 6.6M | 4.9M | 6.8M |
Total Liabilities | 10.9M | 18.2M | 15.0M | 12.9M | 16.5M |
Equity | |||||
Common Stock | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M |
Retained Earnings | 9.9M | 11.3M | 9.6M | 13.4M | 9.4M |
Treasury Stock | 142.0K | 142.0K | 142.0K | 142.0K | 142.0K |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 31.7M | 30.6M | 27.9M | 36.1M | 26.0M |
Key Metrics | |||||
Total Debt | 3.0M | 3.2M | 3.3M | 2.2M | 3.7M |
Working Capital | 21.7M | 21.6M | 18.7M | 29.2M | 23.7M |
Balance Sheet Composition
Naturhouse Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 13.5M | 15.4M | 13.1M | 18.2M | 13.5M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -350.0K | -417.0K | -3.4M | 1.8M | 764.0K |
Operating Cash Flow | 14.2M | 15.6M | 9.8M | 19.8M | 14.4M |
Investing Activities | |||||
Capital Expenditures | 189.0K | 49.0K | 0 | - | - |
Acquisitions | - | 0 | -4.4M | -3.5M | 0 |
Investment Purchases | 0 | 0 | -692.0K | -703.0K | 0 |
Investment Sales | 1.0M | 62.0K | 826.0K | 0 | 132.0K |
Investing Cash Flow | 1.2M | 111.0K | -4.3M | -4.2M | 132.0K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -12.0M | -6.0M | -18.0M | -3.6M | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | -4.1M | -1.7M | - | -2.7M | -3.4M |
Financing Cash Flow | -16.1M | -7.7M | -18.0M | -6.3M | -3.4M |
Free Cash Flow | 11.2M | 20.4M | 6.1M | 16.1M | 14.4M |
Net Change in Cash | -666.0K | 8.0M | -12.4M | 9.3M | 11.2M |
Cash Flow Trend
Naturhouse Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
11.88
Forward P/E
9.05
Price to Book
3.60
Price to Sales
2.30
PEG Ratio
9.05
Profitability Ratios
Profit Margin
19.96%
Operating Margin
23.24%
Return on Equity
31.65%
Return on Assets
17.96%
Financial Health
Current Ratio
4.36
Debt to Equity
13.48
Beta
0.59
Per Share Data
EPS (TTM)
€0.16
Book Value per Share
€0.53
Revenue per Share
€0.82
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
nth | 113.9M | 11.88 | 3.60 | 31.65% | 19.96% | 13.48 |
Ebro Foods, S.A | 2.7B | 13.73 | 1.24 | 9.72% | 6.33% | 25.71 |
Deoleo S.A | 90.0M | 19.98 | 0.43 | -12.07% | -3.00% | 33.16 |
Coca-Cola | 35.4B | 23.20 | 4.41 | 17.93% | 7.35% | 141.24 |
Puig Brands S.A | 2.5B | 27.29 | 3.83 | 48.50% | 9.12% | 71.01 |
Proper Education | 1.5B | 27.90 | 49.04 | 202.53% | 13.95% | 0.25 |
Financial data is updated regularly. All figures are in the company's reporting currency.